Genetic Vaccines and Therapy · 2005 · 19 citations · 45 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationVaccine ImmunologyVaccinologyDna VaccinesImmune Response To VaccinationNucleic Acid VaccinesVaccinationVaccine DeliveryViral VaccinesCd8 Positive T Cell ResponsesPlasmid Vaccine VectorsT-cell Immune ResponsesT-cell Mediated ResponsesVaccine Adjuvant TherapyVaccine-induced T Cell ImmunityVaccine-induced T-cell ResponsesViral Replication Control
Several studies have shown that cell-mediated immune responses play a crucial role in controlling viral replication. As such, a candidate SARS vaccine should elicit broad CD8+ T-cell immune responses. Several groups of mice were immunized alone or in combination with SARS-nucleocapsid immunogen. A high level of specific SARS-CD8+ T-cell response was demonstrated in mice that received DNA encoding the SARS-nucleocapsid, protein and XIAP as an adjuvant. We also observed that co-administration of a plasmid expressing nucleocapsid, recombinant protein and montanide/CpG induces high antibody titers in immunized mice. Moreover, this vaccine approach merits further investigation as a potential candidate vaccine against SARS.
45
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Wenhui Li, Michael J. Moore, Natalya Vasilieva et al. · Nature · 2003 · 6.3K citations · Full text
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
Zhi-Yong Yang, Wing-Pui Kong, Yue Huang et al. · Nature · 2004 · 687 citations · Full text
Kristin M. Sanderson, Ronald Scotland, Peter P. Lee et al. · Journal of Clinical Oncology · 2004 · 433 citations
Yuxian He, Yusen Zhou, Shuwen Liu et al. · Biochemical and Biophysical Research Communications · 2004 · 429 citations · Full text
Ursula J. Buchholz, Alexander Bukreyev, Lijuan Yang et al. · Proceedings of the National Academy of Sciences · 2004 · 414 citations · Full text